A private prescription is a medication you pay for in full, prescribed during a private medical consultation. Unlike NHS prescriptions, which are subsidised by the government, private prescriptions are not.
Additionally, some drugs on private prescriptions aren’t available on the NHS. These can include new medications or those not yet approved for NHS use.
Getting a private prescription involves paying for the consultation with the private healthcare provider, unlike NHS consultations, which are typically free. Private healthcare often means shorter wait times and more flexible appointments compared to NHS services.
To get a private prescription, you need to schedule a consultation with a private GP or specialist, which can be done through online searches or referrals.
How much does a private prescription cost?
The cost of a private prescription varies based on several factors. Firstly, the healthcare provider’s fees differ. Private GPs and specialists charge different consultation fees, which depend on their location, expertise, and the type of service.
The type of medication also affects the cost. Branded medications are usually more expensive than generic ones. Newer or less common medications tend to be pricier. The complexity of the medication matters too; treatments for chronic conditions or rare diseases are generally more expensive than standard medications.
Frequently asked questions about private prescriptions
What is the average cost of a private prescription?
The average cost of a private prescription varies depending on the medication and healthcare provider. It typically ranges from £15 to £200.
How much does it cost to get a private prescription from a private GP?
The cost of a private prescription from a private GP can vary widely, typically ranging from £20 to £250, depending on the consultation fee and medication prescribed.
Are private prescription prices higher for branded medications?
Yes, private prescription prices are often higher for branded medications compared to generic equivalents. Brand-name drugs can be significantly more expensive due to research, development, and marketing costs.
